{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:37:51Z","timestamp":1788305871577,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-11302035"],"award-info":[{"award-number":["NCKUH-11302035"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.diabet.2024.101545","type":"journal-article","created":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T23:25:50Z","timestamp":1716161150000},"page":"101545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study"],"prefix":"10.1016","volume":"50","author":[{"given":"Yu-Chi","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Chia-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Cian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2024.101545_bib0001","doi-asserted-by":"crossref","first-page":"Np1","DOI":"10.1177\/1558944718810855","article-title":"The direct and indirect costs to society of carpal tunnel release","volume":"15","author":"Gabrielli","year":"2020","journal-title":"Hand"},{"key":"10.1016\/j.diabet.2024.101545_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002614","article-title":"Diabetic hand: prevalence and incidence of diabetic hand problems using data from 1.1 million inhabitants in southern Sweden","volume":"10","author":"Rydberg","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabet.2024.101545_bib0003","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/jcm11061674","article-title":"Carpal tunnel syndrome and diabetes-a comprehensive review","volume":"11","author":"Zimmerman","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabet.2024.101545_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.864332","article-title":"Sodium Glucose cotransporter-2 inhibitor protects against diabetic neuropathy and nephropathy in modestly controlled type 2 diabetes: follow-up study","volume":"13","author":"Ishibashi","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabet.2024.101545_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.926717","article-title":"The outcomes of sodium-glucose co-transporter 2 inhibitors (SGLT2I) on Diabetes-associated neuropathy: a systematic review and meta-analysis","volume":"13","author":"Kandeel","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabet.2024.101545_bib0006","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2337\/dc23-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101545_bib0007","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.diabet.2024.101545_bib0008","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/dom.13488","article-title":"Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: is low-grade inflammation the neglected component?","volume":"20","author":"Prattichizzo","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2024.101545_bib0009","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1038\/s41598-019-51343-1","article-title":"Hypoxia-inducible factor-1\u03b1 is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy","volume":"9","author":"Bessho","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabet.2024.101545_bib0010","first-page":"4","article-title":"Pathophysiology of carpal tunnel syndrome","volume":"20","author":"Aboonq","year":"2015","journal-title":"Neurosciences"},{"key":"10.1016\/j.diabet.2024.101545_bib0011","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1016\/j.diabet.2024.101545_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.32584","article-title":"Comparison of sodium-glucose cotransporter 2 inhibitors vs glucagonlike peptide-1 receptor agonists and incidence of dry eye disease in patients with type 2 diabetes in Taiwan","volume":"5","author":"Su","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.diabet.2024.101545_bib0013","article-title":"Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: a real-world study","volume":"50","author":"Su","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101545_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.104140","article-title":"Appropriateness of carpal tunnel syndrome management compared with the AAOS appropriate use criteria: a retrospective review across various specialties","volume":"80","author":"Salman","year":"2022","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.diabet.2024.101545_bib0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.apmr.2021.07.804","article-title":"Increased risk of carpal tunnel syndrome in people with spinal cord injury: a nationwide longitudinal follow-up study","volume":"103","author":"Chiu","year":"2022","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.diabet.2024.101545_bib0016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ckj\/sfz170","article-title":"The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?","volume":"13","author":"Sarafidis","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.diabet.2024.101545_bib0017","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/M18-3079","article-title":"Graphical depiction of longitudinal study designs in health care databases","volume":"170","author":"Schneeweiss","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2024.101545_bib0018","doi-asserted-by":"crossref","first-page":"e3959","DOI":"10.1097\/GOX.0000000000003959","article-title":"Demographic disparities amongst patients receiving carpal tunnel release: a retrospective review of 92,921 Patients","volume":"9","author":"Brodeur","year":"2021","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.diabet.2024.101545_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/atm.2018.12.10","article-title":"Balance diagnostics after propensity score matching","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.diabet.2024.101545_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.berh.2011.01.014","article-title":"Carpal tunnel syndrome: the role of occupational factors","volume":"25","author":"Palmer","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.diabet.2024.101545_bib0021","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/rheumatology\/ker228","article-title":"Occupation and epicondylitis: a population-based study","volume":"51","author":"Walker-Bone","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.diabet.2024.101545_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2016.12.001","article-title":"Criteria for use of composite end points for competing risks-a systematic survey of the literature with recommendations","volume":"82","author":"Manja","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabet.2024.101545_bib0023","article-title":"Aldose reductase inhibitors for the treatment of diabetic polyneuropathy","volume":"2007","author":"Chalk","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diabet.2024.101545_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1762164","article-title":"SGLT2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors in diabetes and microvascular complications: a review","volume":"2020","author":"El Mouhayyar","year":"2020","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.diabet.2024.101545_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101331","article-title":"The impact of canagliflozin on the risk of neuropathy events: a post-hoc exploratory analysis of the CREDENCE trial","volume":"48","author":"Liao","year":"2022","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101545_bib0026","article-title":"Neuroprotective mechanisms of glucagon-like peptide-1-based therapies in ischemic stroke: an update based on preclinical research","volume":"13","author":"Yang","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.diabet.2024.101545_bib0027","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11154-023-09807-3","article-title":"Effects of GLP-1 receptor agonists on neurological complications of diabetes","volume":"24","author":"Garc\u00eda-Casares","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.diabet.2024.101545_bib0028","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.diabet.2018.09.005","article-title":"Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease","volume":"44","author":"Bonnet","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101545_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.diabet.2024.101545_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.diabet.2024.101545_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabet.2024.101545_bib0032","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.diabet.2024.101545_bib0033","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3389\/fphar.2019.00789","article-title":"Liraglutide increases VEGF expression via CNPY2-PERK pathway induced by hypoxia\/reoxygenation injury","volume":"10","author":"Liu","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabet.2024.101545_bib0034","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0404.2007.00797.x","article-title":"Carpal tunnel syndrome and metabolic syndrome","volume":"116","author":"Balci","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.diabet.2024.101545_bib0035","doi-asserted-by":"crossref","first-page":"e34468","DOI":"10.1097\/MD.0000000000034468","article-title":"Body mass index and carpal tunnel syndrome: a case-control study","volume":"102","author":"Chen","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.diabet.2024.101545_bib0036","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/s12891-023-06881-1","article-title":"Characteristics of diabetic and non-diabetic carpal tunnel syndrome in terms of clinical, electrophysiological, and Sonographic features: a cross-sectional study","volume":"24","author":"Park","year":"2023","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.diabet.2024.101545_bib0037","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cjca.2021.05.012","article-title":"Emulating a randomised controlled trial with observational data: an introduction to the target trial framework","volume":"37","author":"Kutcher","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.diabet.2024.101545_bib0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.diabet.2024.101545_bib0039","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40471-014-0027-z","article-title":"Misclassification in administrative claims data: quantifying the impact on treatment effect estimates","volume":"1","author":"Funk","year":"2014","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.diabet.2024.101545_bib0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9305","article-title":"Comparative outcomes of empagliflozin to dapagliflozin in patients with heart failure","volume":"7","author":"Modzelewski","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363624000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363624000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T02:32:17Z","timestamp":1720146737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363624000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1262363624000375"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2024.101545","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2024.101545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101545"}}